Management of bone disease with concurrent chimeric antigen receptor T-cell therapy for multiple myeloma.
Kuruvilla D, Huynh T, Nester M, Chose C, Zervoudakis G, Letson GD, Joyce DM, Binitie OT, Figura NB, Costello JR, Freeman CL, Lazarides AL.
Kuruvilla D, et al.
Crit Rev Oncol Hematol. 2024 Sep;201:104429. doi: 10.1016/j.critrevonc.2024.104429. Epub 2024 Jun 26.
Crit Rev Oncol Hematol. 2024.
PMID: 38942219
Review.